[Federal Register Volume 64, Number 151 (Friday, August 6, 1999)]
[Notices]
[Page 42987]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-20228]



[[Page 42987]]

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances; Notice of Registration

    By Notice dated April 26, 1999, and published in the Federal 
Register on May 7, 1999, (64 FR 24679), Noramco of Delaware, Inc., 
Division of McNeilab, Inc., 500 Old Swedes Landing Road, Wilmington, 
Delaware 19801, made application by renewal to the Drug Enforcement 
Administration to be registered as an importer of the basic classes of 
controlled substances listed below:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Opium, raw (9600)..........................  II
Poppy Straw Concentrate (9670).............  II
------------------------------------------------------------------------

    The firm intends to import the listed controlled substances to 
produce codeine phosphate, codeine sulfate, morphine sulfate, oxycodone 
and hyrocodone.
    No comments or objections have been received. DEA has considered 
the factors in Title 21, United States Code, section 823(a) and 
determined that the registration of Noramco of Delaware, Inc. to import 
the listed controlled substances is consistent with the public interest 
and with United States obligations under international treaties, 
conventions, or protocols in effect on May 1, 1971, at this time. DEA 
has investigated Noramco of Delaware, Inc. on a regular basis to ensure 
that the company's continued registration is consistent with the public 
interest. These investigations have included inspection and testing of 
the company's physical security systems, audits of the company's 
records, verification of the company's compliance with state and local 
laws, and a review of the company's background and history. Therefore, 
pursuant to Section 1008(a) of the Controlled Substances Import and 
Export Act and in accordance with Title 21, Code of Federal 
Regulations, section 1301.34, the above firm is granted registration as 
an importer of the basic classes of controlled substances listed above.

    Dated: July 1, 1999.
John H. King,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 99-20228 Filed 8-5-99; 8:45 am]
BILLING CODE 4140-09-M